mRNA Therapeutics Market, By Product Type (mRNA Vaccines and mRNA Therapeutics), By Therapeutic Area, By Delivery System, By Technology, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4040
|
Published Date
June 2025
|
Pages
365
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
The mRNA Therapeutics Market size was valued at US$ 13,456.13 Million in 2024, expanding at a CAGR of 16.98% from 2025 to 2032.
The mRNA Therapeutics Market centers on the development and use of messenger RNA-based treatments that direct cells to produce specific proteins, triggering therapeutic effects within the body. Market growth is driven by rapid advancements in mRNA technology, a rising global burden of chronic and infectious diseases, and the unprecedented success of mRNA-based COVID-19 vaccines—over 4 billion doses of which have been administered worldwide. While the potential of mRNA is significant, the market faces key challenges, including the inherent instability of mRNA molecules, high manufacturing costs, and complex regulatory approval pathways. Despite these hurdles, the market presents substantial opportunities. Researchers and biotech companies are expanding mRNA applications beyond vaccines into areas such as cancer immunotherapy, treatment of rare genetic disorders, and personalized medicine.
Supportive government initiatives and increasing investment from pharmaceutical companies are accelerating innovation in drug delivery systems, such as lipid nanoparticles and polymer-based carriers, to enhance stability and targeted delivery. As these innovations continue to mature, the mRNA therapeutics market is poised for transformative impact across multiple areas of healthcare.
mRNA Therapeutics Market- Market Dynamics
Advancements in mRNA Technology Poised to Drive Therapeutic Innovation
Advancements in mRNA technology are reshaping the landscape of therapeutic development, with the success of mRNA-based COVID-19 vaccines serving as a pivotal breakthrough. According to the U.S. Centers for Disease Control and Prevention (CDC), over 700 million doses of mRNA COVID-19 vaccines have been administered in the United States alone, underscoring their safety, efficacy, and public acceptance.
Building on this momentum, ongoing research is expanding the application of mRNA therapeutics beyond infectious diseases to include cancer treatment, rare genetic disorders, and other complex conditions. Government support, particularly through initiatives like the National Institutes of Health (NIH) funding programs, is playing a crucial role in driving innovation and addressing unmet medical needs. Despite the progress, challenges such as ensuring mRNA stability and developing efficient delivery systems remain. However, growing collaborations between biotechnology companies and academic research institutions are helping to overcome these barriers. These partnerships are accelerating the development of mRNA-based personalized medicine, offering the potential for more targeted, effective, and accessible treatments on a global scale.
mRNA Therapeutics Market- Segmentation Analysis:
The Global mRNA Therapeutics Market is segmented on the basis of Product Type, Therapeutic Area, Delivery System, Technology, End User, and Region.
The market is divided into two main product types: mRNA Vaccines and mRNA Therapeutics. mRNA vaccines dominate the landscape, largely driven by their widespread application in infectious disease prevention, most notably during the COVID-19 pandemic. These vaccines have demonstrated rapid development timelines and high efficacy, propelling them to the forefront of preventive healthcare. Meanwhile, mRNA therapeutics are gaining momentum, especially in the treatment of rare diseases and cancer, leveraging advances in delivery technologies to target complex conditions more effectively. According to the U.S. Biomedical Advanced Research and Development Authority (BARDA), federal investment in mRNA vaccine development exceeded $10 billion between 2020 and 2024, underscoring the government’s pivotal role in accelerating vaccine availability and adoption.
In terms of therapeutic areas, the market is segmented into Infectious Diseases, Cancer, Genetic Disorders, Rare Diseases, and Cardiovascular Disorders. Infectious diseases remain the primary focus for vaccine development, reflecting the urgent public health need and extensive ongoing research. Cancer represents a rapidly expanding area for mRNA therapeutics, with numerous promising candidates progressing through clinical trials aimed at personalized immunotherapy. Genetic disorders and rare diseases are emerging as important targets, benefiting from mRNA’s ability to address previously untreatable conditions. Cardiovascular disorders, while currently a smaller segment, are witnessing growing research efforts exploring mRNA-based interventions. Data from the National Institutes of Health (NIH) indicate that federal funding for mRNA research across these therapeutic areas has grown by 35% annually since 2019, highlighting sustained governmental commitment to advancing this versatile technology.
mRNA Therapeutics Market- Geographical Insights
The mRNA therapeutics market exhibits notable geographical variation influenced by healthcare infrastructure, research capacity, and government support. North America leads the market, driven by its advanced biotech hubs and substantial funding from institutions such as the National Institutes of Health (NIH), which accelerates the development and adoption of mRNA therapies. Europe follows closely, benefiting from strong collaborative research networks and regulatory frameworks that foster innovation. In the Asia-Pacific region, countries like China, Japan, and South Korea are rapidly expanding their biotechnology capabilities, supported by increasing investments and growing awareness of personalized medicine. According to the World Health Organization (WHO), global government spending on biotechnology and innovative therapeutics has increased by over 15% annually since 2020, reflecting a widespread commitment to advancing these technologies. Conversely, regions such as Africa and Latin America face challenges due to limited healthcare infrastructure and restricted access to advanced technologies, which hamper market growth. Nevertheless, international collaborations and global health initiatives are actively working to bridge these gaps. Overall, the global market is increasingly focusing on localized manufacturing and distribution strategies to enhance accessibility and address the diverse healthcare needs of patients worldwide.
mRNA Therapeutics Market- Competitive Landscape:
The competitive landscape of the mRNA therapeutics market is marked by the strong presence of leading biotechnology and pharmaceutical companies that are heavily investing in research and development to expand and refine their mRNA platforms. These industry players are increasingly pursuing strategic collaborations, partnerships, and acquisitions to bolster their technological capabilities and diversify their therapeutic pipelines. A key area of competition lies in the development of advanced delivery systems—particularly lipid nanoparticles (LNPs)—which are critical to enhancing the stability, bioavailability, and overall efficacy of mRNA-based treatments. In parallel, emerging biotech startups are contributing innovative approaches that drive technological advancement and foster a dynamic, competitive environment. Companies are also scaling up their manufacturing infrastructure to meet the growing global demand for mRNA therapeutics, particularly as applications expand beyond infectious diseases to oncology, rare genetic disorders, and personalized medicine. Supportive regulatory environments, including fast-track designations and expedited approval pathways, are further intensifying market competition, as firms aim to secure early-mover advantage in high-impact therapeutic areas such as cancer immunotherapy.
Recent Developments:
- April 2025: Arcturus Therapeutics received U.S. FDA Fast Track designation for its mRNA-based candidate ARCT-032, developed for cystic fibrosis. This status accelerates development and review, addressing critical unmet medical needs.
- January 2025: Esphera SynBio launched a project aimed at enhancing mRNA vaccine and therapeutic technologies, focusing on improved efficacy, stability, and delivery for broader applications beyond infectious diseases.
- January 2024: SCHOTT Pharma introduced EVERIC® freeze vials, engineered for ultra-cold storage down to -80°C. These vials are designed to support the transport and preservation of mRNA and gene therapy drugs by reducing breakage risk and ensuring product stability.
- August 2024: Everest Medicines initiated a clinical trial in China for a personalized mRNA cancer vaccine, assessing its safety and efficacy. The trial represents a key step toward advancing tailored mRNA-based oncology treatments.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MRNA THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Arcturus Therapeutics
- AstraZeneca
- BioNTech SE
- Chimeron Bio
- CureVac AG
- Daiichi Sankyo
- eTheRNA Immunotherapies
- Gennova Biopharmaceuticals
- GreenLight Biosciences
- Moderna, Inc.
- Omega Therapeutics
- Pfizer
- Sanofi
- Strand Therapeutics
- Translate Bio (Sanofi)
- Ziphius Vaccines
- Others
GLOBAL MRNA THERAPEUTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- mRNA Vaccines
- mRNA Therapeutics
GLOBAL MRNA THERAPEUTICS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032
- Infectious Diseases
- Cancer
- Genetic Disorders
- Rare Diseases
- Cardiovascular Disorders
GLOBAL MRNA THERAPEUTICS MARKET, BY DELIVERY SYSTEM- MARKET ANALYSIS, 2019 - 2032
- Lipid Nanoparticles (LNPs)
- Polymeric Nanoparticles
- Cationic Emulsions
- Peptide-based Delivery
GLOBAL MRNA THERAPEUTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032
- Prophylactic Vaccines
- Therapeutic Vaccines
- Protein Replacement Therapies
- Personalized Medicine
GLOBAL MRNA THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Research Institutes
- Hospitals & Clinics
- Government/Public Health Bodies
GLOBAL MRNA THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. mRNA Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. mRNA Therapeutics Market Snippet by Product Type
2.1.2. mRNA Therapeutics Market Snippet by Therapeutic Area
2.1.3. mRNA Therapeutics Market Snippet by Delivery System
2.1.4. mRNA Therapeutics Market Snippet by Application
2.1.5. mRNA Therapeutics Market Snippet by End User
2.1.6. mRNA Therapeutics Market Snippet by Country
2.1.7. mRNA Therapeutics Market Snippet by Region
2.2. Competitive Insights
3. mRNA Therapeutics Key Market Trends
3.1. mRNA Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. mRNA Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. mRNA Therapeutics Market Opportunities
3.4. mRNA Therapeutics Market Future Trends
4. mRNA Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. mRNA Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. mRNA Therapeutics Market Landscape
6.1. mRNA Therapeutics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. mRNA Therapeutics Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
7.1.2. mRNA Vaccines
7.1.3. mRNA Therapeutics
8. mRNA Therapeutics Market – By Therapeutic Area
8.1. Overview
8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
8.1.2. Infectious Diseases
8.1.3. Cancer
8.1.4. Genetic Disorders
8.1.5. Rare Diseases
8.1.6. Cardiovascular Disorders
9. mRNA Therapeutics Market – By Delivery System
9.1. Overview
9.1.1. Segment Share Analysis, By Delivery System, 2024 & 2032 (%)
9.1.2. Lipid Nanoparticles (LNPs)
9.1.3. Polymeric Nanoparticles
9.1.4. Cationic Emulsions
9.1.5. Peptide-based Delivery
10. mRNA Therapeutics Market – By Application
10.1. Overview
10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
10.1.2. Prophylactic Vaccines
10.1.3. Therapeutic Vaccines
10.1.4. Protein Replacement Therapies
10.1.5. Personalized Medicine
11. mRNA Therapeutics Market – By End User
11.1. Overview
11.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
11.1.2. Pharmaceutical Companies
11.1.3. Research Institutes
11.1.4. Hospitals & Clinics
11.1.5. Government/Public Health Bodies
12. mRNA Therapeutics Market– By Geography
12.1. Introduction
12.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
12.2. North America
12.2.1. Overview
12.2.2. mRNA Therapeutics Key Manufacturers in North America
12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.2.6. North America Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.9. U.S.
12.2.9.1. Overview
12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.9.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.9.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.2.9.5. U.S. Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.2.9.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.2.10. Canada
12.2.10.1. Overview
12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.2.10.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.2.10.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.2.10.5. Canada Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.2.10.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3. Europe
12.3.1. Overview
12.3.2. mRNA Therapeutics Key Manufacturers in Europe
12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.6. Europe Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.9. Germany
12.3.9.1. Overview
12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.9.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.9.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.9.5. Germany Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.9.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.10. UK
12.3.10.1. Overview
12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.10.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.10.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.10.5. UK Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.10.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.10.7. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.11. France
12.3.11.1. Overview
12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.11.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.11.5. France Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.11.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.11.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.12. Italy
12.3.12.1. Overview
12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.12.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.12.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.12.5. Italy Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.12.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.12.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.13. Spain
12.3.13.1. Overview
12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.13.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.13.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.13.5. Spain Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.13.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.13.7. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.14. The Netherlands
12.3.14.1. Overview
12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.14.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.14.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.14.5. The Netherlands Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.14.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.15. Sweden
12.3.15.1. Overview
12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.15.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.15.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.15.5. Sweden Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.15.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.15.7. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.16. Russia
12.3.16.1. Overview
12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.16.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.16.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.16.5. Russia Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.16.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.16.7. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.17. Poland
12.3.17.1. Overview
12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.17.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.17.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.17.5. Poland Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.17.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.17.7. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.3.18. Rest of Europe
12.3.18.1. Overview
12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.3.18.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.3.18.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.3.18.5. Rest of the Europe Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.3.18.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.3.18.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4. Asia Pacific (APAC)
12.4.1. Overview
12.4.2. mRNA Therapeutics Key Manufacturers in Asia Pacific
12.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.6. APAC Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.8. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.9. China
12.4.9.1. Overview
12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.9.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.9.5. China Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.9.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.9.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.10. India
12.4.10.1. Overview
12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.10.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.10.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.10.5. India Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.10.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.10.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.11. Japan
12.4.11.1. Overview
12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.11.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.11.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.11.5. Japan Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.11.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.12. South Korea
12.4.12.1. Overview
12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.12.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.12.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.12.5. South Korea Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.12.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.13. Australia
12.4.13.1. Overview
12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.13.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.13.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.13.5. Australia Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.13.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.14. Indonesia
12.4.14.1. Overview
12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.14.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.14.5. Indonesia Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.14.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.14.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.15. Thailand
12.4.15.1. Overview
12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.15.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.15.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.15.5. Thailand Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.15.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.15.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.16. Philippines
12.4.16.1. Overview
12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.16.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.16.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.16.5. Philippines Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.16.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.4.17. Rest of APAC
12.4.17.1. Overview
12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.4.17.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.4.17.5. Rest of APAC Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.4.17.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5. Latin America (LATAM)
12.5.1. Overview
12.5.2. mRNA Therapeutics Key Manufacturers in Latin America
12.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.6. LATAM Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.8. LATAM Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.9. Brazil
12.5.9.1. Overview
12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.9.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.9.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.9.5. Brazil Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.9.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.10. Mexico
12.5.10.1. Overview
12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.10.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.10.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.10.5. Mexico Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.10.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.11. Argentina
12.5.11.1. Overview
12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.11.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.11.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.11.5. Argentina Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.11.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.12. Colombia
12.5.12.1. Overview
12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.12.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.12.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.12.5. Colombia Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.12.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.5.13. Rest of LATAM
12.5.13.1. Overview
12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.5.13.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.5.13.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.5.13.5. Rest of LATAM Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.5.13.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6. Middle East and Africa
12.6.1. Overview
12.6.2. mRNA Therapeutics Key Manufacturers in Middle East and Africa
12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
12.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.6. Middle East and Africa Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.7. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.9. Saudi Arabia
12.6.9.1. Overview
12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.9.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.9.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.9.5. Saudi Arabia Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.9.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.10. United Arab Emirates
12.6.10.1. Overview
12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.10.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.10.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.10.5. United Arab Emirates Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.10.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.11. Israel
12.6.11.1. Overview
12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.11.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.11.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.11.5. Israel Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.11.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.12. Turkey
12.6.12.1. Overview
12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.12.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.12.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.12.5. Turkey Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.12.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.13. Algeria
12.6.13.1. Overview
12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.13.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.13.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.13.5. Algeria Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.13.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.14. Egypt
12.6.14.1. Overview
12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.14.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.14.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.14.5. Egypt Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.14.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
12.6.15. Rest of MEA
12.6.15.1. Overview
12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
12.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
12.6.15.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
12.6.15.5. Rest of MEA Market Size and Forecast, By Delivery System, 2019 - 2032 (US$ Million)
12.6.15.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- mRNA Therapeutics Industry
13.1. Competitive Dashboard
13.1.1. Competitive Benchmarking
13.1.2. Competitive Positioning
13.2. Company Profiles
13.2.1. Arcturus Therapeutics
13.2.2. AstraZeneca
13.2.3. BioNTech SE
13.2.4. Chimeron Bio
13.2.5. CureVac AG
13.2.6. Daiichi Sankyo
13.2.7. eTheRNA Immunotherapies
13.2.8. Gennova Biopharmaceuticals
13.2.9. GreenLight Biosciences
13.2.10. Moderna, Inc.
13.2.11. Omega Therapeutics
13.2.12. Pfizer
13.2.13. Sanofi
13.2.14. Strand Therapeutics
13.2.15. Translate Bio (Sanofi)
13.2.16. Ziphius Vaccines
13.2.17. Others
14. 360 Degree Analyst View
15. Appendix
15.1. Research Methodology
15.2. References
15.3. Abbreviations
15.4. Disclaimer
15.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
